rxstat › Prices in Saskatchewan › Mepolizumab
Mepolizumab (Nucala) price and coverage in Saskatchewan
Mepolizumab 100 mg/ml solution lists at $22.07 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Mepolizumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.
Price by strength in Saskatchewan
| Strength and form | Lowest price | Brand |
|---|---|---|
| 100 mg/ml Solution2 products · special approval | $22.07/unit | – |
| 100 mg/vial Powder For Solution1 product · special approval | $20.59/unit | – |
All 3 products listed in Saskatchewan
| Product | Price | Coverage |
|---|---|---|
| 100 mg/ml Solution | ||
| NucalaGSK · DIN 02492989 | $22.07/unit | Special approval |
| NucalaGSK · DIN 02492997 | $22.07/unit | Special approval |
| 100 mg/vial Powder For Solution | ||
| NucalaGSK · DIN 02449781 | $20.59/unit | Special approval |
What you'll pay at the pharmacy
These are the prices the Saskatchewan Drug Plan lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
No active shortage is reported for Mepolizumab in Canada. Full drug page.
Mepolizumab price in other provinces
Common questions
How much does Mepolizumab cost in Saskatchewan?
Mepolizumab 100 mg/ml solution lists at $22.07 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Mepolizumab covered in Saskatchewan?
Mepolizumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.
Source: Saskatchewan Drug Plan Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.